Vital Chemtech Limited (NSE:VITAL)
India · Delayed Price · Currency is INR 53.05
-0.30 (-0.56%)
Feb 13, 2026, 3:27 PM IST
Vital Chemtech Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,325 | 1,339 | 982.74 | 1,167 | 576.15 | 473.97 |
Other Revenue | - | - | - | 0 | -0 | 0.07 |
| 1,325 | 1,339 | 982.74 | 1,167 | 576.15 | 474.03 | |
Revenue Growth (YoY) | 15.82% | 36.26% | -15.82% | 102.63% | 21.54% | 15.17% |
Cost of Revenue | 1,085 | 1,065 | 759.46 | 859.89 | 391.87 | 317.45 |
Gross Profit | 240.48 | 274.02 | 223.28 | 307.55 | 184.28 | 156.58 |
Selling, General & Admin | 64.24 | 61.29 | 36.86 | 29.36 | 19.12 | 28.08 |
Other Operating Expenses | 64.08 | 98.82 | 187.09 | 128.63 | 49.21 | 63.91 |
Operating Expenses | 181.21 | 209.85 | 250.29 | 181.17 | 75.29 | 101.18 |
Operating Income | 59.27 | 64.16 | -27.01 | 126.38 | 108.99 | 55.4 |
Interest Expense | -18.41 | -19.41 | -6.78 | -5.7 | -1.69 | -9.47 |
Interest & Investment Income | 17.41 | 17.41 | 23.46 | 7.28 | 0.53 | 1.96 |
Currency Exchange Gain (Loss) | 2.26 | 2.26 | 7.41 | -7.48 | 1.31 | 0.82 |
Other Non Operating Income (Expenses) | -10.02 | -2.34 | -5.69 | -5.53 | -3.15 | -1.63 |
EBT Excluding Unusual Items | 50.5 | 62.09 | -8.61 | 114.95 | 105.98 | 47.08 |
Gain (Loss) on Sale of Investments | - | - | 4.95 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 0.13 | -0.1 | - | - |
Pretax Income | 50.5 | 62.09 | -3.53 | 114.85 | 105.98 | 47.08 |
Income Tax Expense | 19.53 | 21.53 | 9.5 | 34.33 | 27 | 17.7 |
Net Income | 30.97 | 40.56 | -13.02 | 80.51 | 78.98 | 29.38 |
Net Income to Common | 30.97 | 40.56 | -13.02 | 80.51 | 78.98 | 29.38 |
Net Income Growth | - | - | - | 1.94% | 168.85% | 178.78% |
Shares Outstanding (Basic) | 25 | 24 | 24 | 18 | 7 | 11 |
Shares Outstanding (Diluted) | 25 | 24 | 24 | 18 | 7 | 11 |
Shares Change (YoY) | 3.22% | 0.20% | 33.87% | 166.18% | -39.99% | - |
EPS (Basic) | 1.26 | 1.69 | -0.54 | 4.50 | 11.75 | 2.62 |
EPS (Diluted) | 1.26 | 1.69 | -0.54 | 4.50 | 11.75 | 2.62 |
EPS Growth | - | - | - | -61.70% | 348.47% | 178.72% |
Free Cash Flow | -539.15 | -396.23 | -68.25 | -178.22 | -219.24 | 30.96 |
Free Cash Flow Per Share | -21.91 | -16.51 | -2.85 | -9.96 | -32.62 | 2.76 |
Dividend Per Share | - | - | 0.500 | 0.500 | - | - |
Gross Margin | 18.14% | 20.46% | 22.72% | 26.34% | 31.99% | 33.03% |
Operating Margin | 4.47% | 4.79% | -2.75% | 10.82% | 18.92% | 11.69% |
Profit Margin | 2.34% | 3.03% | -1.32% | 6.90% | 13.71% | 6.20% |
Free Cash Flow Margin | -40.68% | -29.59% | -6.94% | -15.27% | -38.05% | 6.53% |
EBITDA | 112.16 | 113.91 | -0.68 | 149.55 | 115.95 | 64.59 |
EBITDA Margin | 8.46% | 8.51% | -0.07% | 12.81% | 20.13% | 13.63% |
D&A For EBITDA | 52.89 | 49.75 | 26.33 | 23.18 | 6.96 | 9.19 |
EBIT | 59.27 | 64.16 | -27.01 | 126.38 | 108.99 | 55.4 |
EBIT Margin | 4.47% | 4.79% | -2.75% | 10.82% | 18.92% | 11.69% |
Effective Tax Rate | 38.67% | 34.67% | - | 29.89% | 25.48% | 37.60% |
Revenue as Reported | 1,338 | 1,360 | 1,016 | 1,169 | 578.7 | 476.85 |
Advertising Expenses | - | 0.83 | - | 0.92 | 5.93 | 0.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.